Diagnosis and management of infantile hemangiomas in the neonate

N Harter, AJ Mancini - Pediatric Clinics, 2019 - pediatric.theclinics.com
Infantile hemangiomas (IH) are the most common tumors in children, with an estimated
incidence of 4% to 5%, with higher prevalence noted in Whites, girls, and preterm/low-birth …

Infantile hemangioma: a current review

KS Pahl, TW McLean - Journal of Pediatric Hematology/Oncology, 2022 - journals.lww.com
Infantile hemangiomas (IHs) are common vascular lesions which are benign but can cause
significant functional and cosmetic morbidity. Since the fortuitous discovery of propranolol …

[HTML][HTML] Pediatric dermatology

L Castelo-Soccio, P McMahon - The Journal of clinical and …, 2017 - ncbi.nlm.nih.gov
Pediatric Dermatology - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview improvements …

News on infantile haemangioma. Part 2: therapy and evaluation

J Saerens, H De Leye… - Clinical and experimental …, 2021 - academic.oup.com
Infantile haemangioma (IH) is the most frequently occurring tumour of childhood. While
benign, in more than half of the cases, less or more severe sequelae can be observed. In …

Hemangiol in infantile haemangioma: A paediatric post‐marketing surveillance drug study

F Socchi, M Bigorre, M Normandin… - British Journal of …, 2021 - Wiley Online Library
Aim Infantile haemangioma (IH) is the most common benign tumour in children. Since 2014,
propranolol has become the first‐choice therapy and currently Hemangiol is the only …

Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas

EB Lund, SL Chamlin, AJ Mancini - Pediatric dermatology, 2018 - Wiley Online Library
Screening electrocardiography (ECG) before initiation of propranolol for treatment of
infantile hemangiomas (IH) is controversial. A retrospective chart review was conducted to …

Use of propranolol in infantile hemangioma

MK Shah, RJ Vasani - Indian Journal of Drugs in Dermatology, 2017 - journals.lww.com
Imaging studies including cardiac ultrasound or cardiac magnetic resonance imaging (MRI)
should be obtained in children with large facial hemangiomas at risk for PHACES to rule out …

Antihypertensives in dermatology Part I-Uses of antihypertensives in dermatology

PSS Ranugha, JB Betkerur - Indian journal of dermatology, venereology …, 2018 - ijdvl.com
Hypertension is a global health problem. Antihypertensives are the mainstay of treatment for
hypertension. Some of them were accidentally found to be useful in alopecias and infantile …

Clinical significance of screening electrocardiograms for the administration of propranolol for problematic infantile hemangiomas

JD Phillips, T Merrill, JR Gardner… - … journal of pediatrics, 2021 - Wiley Online Library
Objective. Low‐dose nonselective β blockade is an effective treatment for problematic
infantile hemangioma (PIH). Screening electrocardiograms (ECG) are performed prior to the …

[HTML][HTML] Infantile Hemangioma and Cardiac Defects: a Puzzling Association. A Single-center Experience

A Bassi, A Azzarelli, A Vaccaro… - Dermatology Practical & …, 2022 - ncbi.nlm.nih.gov
Infantile Hemangioma and Cardiac Defects: a Puzzling Association. A Single-center Experience
- PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …